2026 NPPES data Hematology & Oncology Physician NPI 1023022365 M.D.
Verify on CMS →

JOSEPH MCCRACKEN, M.D.

Hematology & Oncology Physician in SAN ANTONIO, Texas. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
107
Medicare Part D claims · 39 beneficiaries · Hematology & Oncology Physician avg: 847
Generic prescribing
72%
generic claims · 28% brand-name · higher generic rates reduce patient out-of-pocket costs

What the federal data shows

JOSEPH MCCRACKEN, M.D. filed 107 Medicare Part D claims in 2023 as a Hematology & Oncology Physician in SAN ANTONIO, Texas, prescribing 72% generic.

107
Part D claims, 2023
72%
generic prescribing

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

JOSEPH MCCRACKEN, M.D.'s Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

107 35th percentile higher than 35% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). This entry sits in this band. 200–400: 182,923 prescribers (13%). Above this entry. 400–600: 90,619 prescribers (7%). Above this entry. 600–800: 56,224 prescribers (4%). Above this entry. 800–1,000: 40,919 prescribers (3%). Above this entry. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2,000–2,200: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board-eligible specialty (heuristic — not verified)

JOSEPH MCCRACKEN, M.D. practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about JOSEPH MCCRACKEN, M.D.?

Quality data not reported

NPI registry status

Active

Issued 07/29/2006

NPI 1023022365

Primary specialty

Hematology & Oncology Physician

Mid-sized

11,215 US NPIs in this specialty

Medicare Part D claims

107 87% vs specialty avg

2023 prescription claims

Specialty avg: 847

Specialty distribution in Texas

How Hematology & Oncology Physician compares to other specialties among Texas providers

Texas providers

Hematology & Oncology Physician share within Texas

1. Hematology & Oncology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Hematology & Oncology Physician share within Texas

Specialty board-certification context

Estimated specialty board-certified rate — Hematology & Oncology Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Hematology & Oncology Physician ABMS/AOA estimate

Est. board-certified rate (Hematology & Oncology Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Hematology & Oncology Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

JOSEPH MCCRACKEN, M.D. appears in the CMS NPPES registry as a Hematology & Oncology Physician provider holding M.D. credentials at 1200 BROOKLYN AVE, SAN ANTONIO, TX, 78212, with a listed phone of (210) 224-6531. NPI 1023022365 was issued on 07/29/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what MCCRACKEN most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 107 prescription claims written by this provider, covering 39 Medicare beneficiaries and totaling roughly $249K in drug spend, split 28% brand-name and 72% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Hematology & Oncology Physician is a mid-sized specialty nationwide, with 11,215 enrolled providers across 54 states and an average of 847 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

1200 BROOKLYN AVE
SAN ANTONIO, TX 78212

Provider Details

NPI 1023022365
Specialty Hematology & Oncology Physician
Credentials M.D.
Gender Male
NPI Issued 07/29/2006

License & disciplinary context — Texas TMB 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~77K Texas medical licensees in 2023 — they are NOT specific to JOSEPH MCCRACKEN, M.D.. To verify JOSEPH MCCRACKEN, M.D.'s current license status, search the TMB public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

344
Total board actions, Texas 2023
Across 334 cases
4.47
Actions per 1,000 licensees
Texas statewide rate
probation
Most common action type
94 cases

TMB publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Texas disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Above average

JOSEPH MCCRACKEN, M.D. — brand share 28.0%
Specialty average (est.)

28% brand-name claims vs 72% generic, on 107 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

107
Total Claims
$249K
Total Drug Cost
39
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
146
Total Day Supply
4,159
Brand vs Generic
28% brand / 72% generic
Brand Drug Cost
$241K
Generic Drug Cost
$8K

Patient Demographics

Average Patient Age
73.0 years
Avg HCC Risk Score
3.02
Gender Split
44% female / 56% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Levothyroxine Sodium
14
Dexamethasone
13

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Hematology & Oncology Physician Overview

How JOSEPH MCCRACKEN, M.D. fits within the Hematology & Oncology Physician landscape nationally.

11,215
Hematology & Oncology Physician Providers in US
54
States with Hematology & Oncology Physician
847
Avg Claims per Provider

JOSEPH MCCRACKEN, M.D.'s 107 claims are below the specialty average of 847.

Nearby Hematology & Oncology Physician Providers in Texas

Other clinicians with the same primary specialty enrolled in Texas, drawn from the same CMS NPPES roster as MCCRACKEN.

Compare Hematology & Oncology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is JOSEPH MCCRACKEN, M.D.'s specialty?
JOSEPH MCCRACKEN, M.D. specializes in Hematology & Oncology Physician and practices in SAN ANTONIO, Texas. Credentials: M.D..
How much does JOSEPH MCCRACKEN, M.D. prescribe under Medicare Part D?
In 2023, JOSEPH MCCRACKEN, M.D. wrote 107 Medicare Part D claims totaling $249K in drug costs for 39 beneficiaries.
Where is JOSEPH MCCRACKEN, M.D. located?
JOSEPH MCCRACKEN, M.D. is located at 1200 BROOKLYN AVE, SAN ANTONIO, TX, 78212. Phone: (210) 224-6531.
What is JOSEPH MCCRACKEN, M.D.'s NPI number?
JOSEPH MCCRACKEN, M.D.'s National Provider Identifier (NPI) is 1023022365, issued on 07/29/2006.
Does JOSEPH MCCRACKEN, M.D. prescribe more brand-name or generic drugs?
JOSEPH MCCRACKEN, M.D.'s prescribing is 28% brand-name and 72% generic drugs by claim count, with $241K in brand drug costs.
How many Hematology & Oncology Physician providers are there in the US?
There are 11,215 Hematology & Oncology Physician providers across 54 states in the US. The average Hematology & Oncology Physician provider writes 847 Medicare Part D claims per year.
What drugs does JOSEPH MCCRACKEN, M.D. prescribe most often?
Based on 2023 Medicare Part D data, JOSEPH MCCRACKEN, M.D.'s most frequently prescribed drugs include Levothyroxine Sodium, Dexamethasone. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does JOSEPH MCCRACKEN, M.D. accept Medicare?
JOSEPH MCCRACKEN, M.D. appears in CMS Medicare data with 107 Part D claims and 39 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify JOSEPH MCCRACKEN, M.D.'s credentials?
JOSEPH MCCRACKEN, M.D.'s NPI is 1023022365 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology